Molecular Imaging Archives

GE HealthCare Announces Five Global Clinical Collaborations for StarGuide GX Theranostics Imaging

October 21, 2026 GE HealthCare, Molecular Imaging

GE HealthCare has announced a global clinical evaluation program spanning three continents and five institutions to assess its StarGuide GX digital 4D SPECT/CT system across quantitative imaging, dynamic imaging, and emerging theranostic applications, with clinical experience from more than 1,000 patient studies established ahead of the European Association of Nuclear Medicine (EANM) 2026.

Siemens Healthineers Completes $43.6 Million Expansion at Tennessee PET Detector Center

September 10, 2026 Molecular Imaging, Siemens Healthineers

Siemens Healthineers has completed a $43.6 million construction and renovation project at its PET Detector Center in Rockford, Tennessee, adding 40,000 square feet to expand production capacity for PET detector technology and support growing demand for PET/CT scanners.

GE HealthCare’s StarGuide GX 4D SPECT/CT System Now 510(k) Pending with U.S. FDA

September 9, 2026 FDA, GE HealthCare, Molecular Imaging

GE HealthCare has announced that its StarGuide GX digital 4D CZT SPECT/CT system is now 510(k) pending with the U.S. FDA, following recent CE Mark, aiming to expand access to advanced molecular imaging for theranostics and emerging alpha-emitting tracers.

Spectrum Dynamics Medical Unveils All-Energy Enhancement for VERITON-CT 400 Series

July 21, 2026 Molecular Imaging

Spectrum Dynamics Medical has launched an All-Energy Enhancement for its VERITON-CT 400 Series digital SPECT/CT platform, enabling imaging across low-, medium-, and high-energy isotopes including Tc-99m, Lu-177, and I-131 without collimator changes.

GE HealthCare Highlights Nuclear Medicine Innovations at SNMMI 2026 to Expand Access and Support Precision Care

June 3, 2026 GE HealthCare, Molecular Imaging, SNMMI

At the 2026 SNMMI Annual Meeting, GE HealthCare is showcasing its latest nuclear medicine technologies and AI-enabled workflows, including advanced PET/CT and SPECT/CT systems, radiopharmaceuticals, and quantitative analysis software, to help expand access and support precision care.